TRP_1170x120_3-8-19

Dr. Reddy’s Laboratories Ltd.

Dr. Reddy’s launches of over-the-counter store brand equivalent of Prilosec OTC

Dr. Reddy’s launches of over-the-counter store brand equivalent of Prilosec OTC

HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories Ltd.announced today the launch of Omeprazole Delayed-Release Tablets, 20 mg, an over-the-counter (OTC) store-brand equivalent of Prilosec OTC (omeprazole delayed-release) Tablets, 20 mg, in the United States market as approved by the U.S. Food and Drug Administration (USFDA). OTC Omeprazole Delayed-Release Tablets, 20 mg, is a proton

Dr. Reddy’s aims to widen access to affordable Rxs

Dr. Reddy’s aims to widen access to affordable Rxs

HYDERABAD, India — Dr. Reddy’s Laboratories Ltd. is building a pathway to long-term future growth on a strong foundation of capabilities. The innovation-focused pharmaceuticals manufacturer is well positioned to adapt to the swiftly changing global market and emerging opportunities in health care. According to Alok Sonig, chief executive officer for developed markets, Dr. Reddy’s is